Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy

Sexually Transmitted Infections

Volumn 87, Issue 2, 2011, Pages 114-117

  Graham, Susan M ^a,b,c,d   Masese, Linnet ^a,b   Gitau, Ruth ^b   Richardson, Barbra A ^a   Mandaliya, Kishor ^e   Peshu, Norbert ^c   Jaoko, Walter ^b   Ndinya Achola, Jeckoniah ^b   Overbaugh, Julie ^f   McClelland, R Scott ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d UNIVERSITY OF TORONTO   (Canada)

^e Department of Obstetrics and Gynaecology   (Kenya)

^f USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ACICLOVIR; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; STAVUDINE; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENITAL ULCER; GYNECOLOGICAL EXAMINATION; HERPES SIMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPOTHESIS; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UTERINE CERVIX EROSION; UTERINE CERVIX MUCUS; VAGINA SECRETION; VAGINAL ULCER; VIRUS DETECTION; VIRUS SHEDDING; VULVA DISEASE; VULVA ULCER;

ADULT; ANTI-HIV AGENTS; CERVIX UTERI; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MUCUS; PROSPECTIVE STUDIES; RNA, VIRAL; ULCER; UTERINE CERVICAL DISEASES; VAGINA; VAGINAL DISEASES; VIRUS SHEDDING;

EID: 79952103207     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.2010.045369     Document Type: Article

References (16)

1. Ameli N, Bacchetti P, Morrow RA, et al. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS 2006;20:1051-8.
2. McClelland RS, Lavreys L, Katingima C, et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J Infect Dis 2005;191:333-8. (Pubitemid 40139757)
3. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 2008;35:946-59.
4. Suntoke TR, Hardick A, Tobian AA, et al. Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda. Sex Transm Infect 2009;85:97-101.
5. Nagot N, Ouedraogo A, Konate I, et al. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis 2008;198:241-9. (Pubitemid 352035760)
6. Graham SM, Masese L, Gitau R, et al. Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy. J Acquir Immune Defic Syndr 2009;52:600-3.
7. Mayaud P, Nagot N, Konate I, et al. Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Sex Transm Infect 2008;84:332-7.
8. Graham SM, Holte SE, Peshu NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 2007;21:501-7.
9. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004;36:1100-2. (Pubitemid 38989377)
10. World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization, 2003.
11. DeVange Panteleeff D, Emery S, Richardson BA, et al. Validation of performance of the Gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J Clin Microbiol 2002;40:3929-37. (Pubitemid 35285770)
12. Benki S, Mostad SB, Richardson BA, et al. Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle. J Infect Dis 2004;189:2192-201. (Pubitemid 38757191)
13. Nilsen A, Kasubi MJ, Mohn SC, et al. Herpes simplex virus infection and genital ulcer disease among patients with sexually transmitted infections in Dar es Salaam, Tanzania. Acta Derm Venereol 2007;87:355-9.
14. Pickering JM, Whitworth JA, Hughes P, et al. Aetiology of sexually transmitted infections and response to syndromic treatment in southwest Uganda. Sex Transm Infect 2005;81:488-93. (Pubitemid 41811332)
15. Mostad SB, Kreiss JK, Ryncarz AJ, et al. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis 2000;181:58-63. (Pubitemid 30049033)
16. Ouedraogo A, Nagot N, Vergne L, et al. Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial. AIDS 2006;20:2305-13. (Pubitemid 44789532)